Company Overview
- Website
- gnubio.com
- Phone
- (617) 528-4500
- Employees
- 1
- Founded in
- 2009
- Industry
- BioTech/Drugs
- NAICS Codes
-
54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services5417 - Scientific Research and Development Services54171 - Research and Development in the Physical, Engineering, and Life Sciences541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- SIC Codes
-
87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$9B
Recent News & Media
Alumni Profile: David A. Weitz
- Sep 9, 2023
- uwaterloo.ca
BIOS Podcast - Future of Microfluidics with David Weitz - Professor at Harvard/Core Faculty at Wyss Institute
- May 8, 2023
- wyss.harvard.edu
California biotech to shutter Cambridge site, lay off 92 employees here
- Oct 6, 2017
- bizjournals.com
GnuBIO
- Nov 29, 2014
- crunchbase.com
Bio-Rad Grows Droplet-Based DNA Sequencing Business with GnuBio Purchase
- Apr 11, 2014
- insideprecisionmedicine.com
NHGRI Fortifies Third-Generation Sequencing Development with $18M
- Sep 16, 2010
- genengnews.com
Who is GnuBIO
GnuBIO Inc. is a genomics company based in Cambridge, Massachusetts. As a privately held company, GnuBIO employs 1 person and generates an annual revenue of $8.6 million. GnuBIO specializes in DNA sequencing technology, catering to both the diagnostic and scientific research markets. Their innovative instrument leverages advancements in microfluidics and emulsion technology, originally licensed from Harvard University. GnuBIO distinguishes itself through its cutting-edge DNA sequencing technology, which is built upon microfluidics and emulsion technology. This unique approach allows for advancements in the diagnostic and scientific research fields. For more information about GnuBIO and its products, please visit their website at gnuobio.com.